BI-CSPC@EC2611A

SUPERLAND GROUP

OCT (ASIA)

GREAT WORLD

JIAODA WITHUB

CREATIVE CHINA

SMART CITY DEV

DAISHOMICROLINE

RIMBACO

SHENYANG PUBLIC

XUNCE

520880

159570

512290

513120

01093

520690

516500

159892

159849

513060

159506

562050

520500

159992

CSPC Pharmaceutical Group (CHJTF) was upgraded to a Hold rating by Bank of China with a price target of HK$9.10 on March 26, following a close of HK$8.16. UBS also assigned a Hold rating on March 25. Meanwhile, CMB International Securities maintained a Buy rating on the same day.

Tip Ranks

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

Guotai CSI Bio-medicine ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

CSPC PHARMA

Bosera Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC CSI Biotechnology Theme ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

China Merchants CSI Biotechnology Theme ETF

E Fund CSI Biotechnology Theme ETF

Bosera Hang Seng Health Care ETF(QDII)

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Hwabao WP CSI Pharmaceuticals ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Yinhua CSI Innovative Drugs Industry ETF

CSPC Pharmaceutical Group (CHJTF) was upgraded to a Hold Rating at Bank of China

588130

513700

510660

512010

159316

Hong Kong stocks rose repeatedly, with the Hang Seng Index closing up 95 points at 24,951 points. Pharmaceutical stocks performed strongly, with CSPC PHARMA's share price rising nearly 14%. Several blue-chip companies announced their earnings, with CITIC Limited, Longfor, and Meituan seeing their share prices decline, while China Ping An and China Mobile's share prices increased. The total market turnover was HKD 263.081 billion

AASTOCKS

ChinaAMC SSE STAR Biology and Medicine ETF

Minsheng Royal CSI Biotechnology Theme ETF

Penghua CSI HK Connect Health Care Composite ETF

Harvest CNI Communication ETF

First Trust NYSE Arca Biotech Index Fd

ChinaAMC SSE Health Care ETF Initiating Fund

E Fund CSI 300 Health Care ETF

E Fund Hang Seng SCHK Innovative Drug ETF

"Hong Kong Stocks" Hang Seng Index closed up 95 points, pharmaceutical stocks led the rise, CSPC PHARMA surged nearly 14%

01772

03288

01276

01801

01339

02097

06869

06690

03986

CSPC PHARMA(01093) rose 13.85%, with a trading turnover 1.7 Billion HKD, and a year-to-date rose 10.2%. GANFENGLITHIUM(01772) rose 9.26%, with a trading turnover 2.7 Billion HKD, and a year-to-date rose 43%. PICC GROUP(01339) fell 7.18%, with a trading turnover 746.4 Million HKD, and a year-to-date fell 19.6%. MIXUE GROUP(02097) fell 4.86%, with a trading turnover 354.1 Million HKD, and a year-to-date fell 30.2%.

Top Gainers & Losers

GANFENGLITHIUM

HAITIAN FLAV

HENGRUI PHARMA

INNOVENT BIO

PICC GROUP

MIXUE GROUP

YOFC

HAIER SMARTHOME

GIGADEVICE

Top 5 HK Stock Gainers/Losers (>100B) (3.27)

03317

02632

02616

01458

03339

03696

06127

09606

09887

XUNCE(03317) rose 24.26%, with a trading turnover 2.2 Billion HKD, and a year-to-date rose 273.3%. NEW VISION CO(02632) rose 23.93%, with a trading turnover 36.2 Million HKD, and a year-to-date rose 31.2%. CSTONE PHARMA-B(02616) rose 20.72%, with a trading turnover 613.5 Million HKD, and a year-to-date rose 58.1%.

NEW VISION CO

CSTONE PHARMA-B

ZHOU HEI YA

LONKING

INSILICO

JOINN

DUALITYBIO-B

LEADS BIOLABS-B

Top 10 HK Stock Gainers (3.27)

00HSI

03698

03690

002460

The Hang Seng Index closed at 24,951 points, up 95 points or 0.4%. The Hang Seng Tech Index reported 4,778 points, up 16 points or 0.3%. The total market turnover was HKD 263.081 billion. Among the actively traded heavyweights, Ping An rose by 2%, Xiaomi rose by 1.7%, and Meituan fell by 0.9%. CSPC Pharma rose over 13%, XUNCE hit a new high, and trading was active

Hang Seng Index

HUISHANG BANK

MEITUAN

Ganfeng Lithium

According to the "All-Day Express," the Hang Seng Index closed at 24,951 points, up 95 points; the Hang Seng Tech Index closed at 4,778 points, up 16 points. CSPC Pharma rose over 13%, XUNCE, Ganfeng Lithium, Weisheng Holdings, Qingsong Health, and HUISHANG BANK reached new highs with active trading

603127

The Hong Kong innovative drug sector continued to rise in the afternoon, with JOINN and CSPC PHARMA up over 10%, INNOVENT BIO up over 7%, and JUNSHI BIO and INNOCARE following suit

Wallstreetcn

InnoCare Pharma

Huaan Hang Seng Biotech ETF

JUNSHI BIO

Guotai CSI Hugangshen Innovative Drugs Industry ETF

INNOCARE

002594

515030

BYDDY

BYDDF

The Hong Kong stock market rose in the morning session, with the Hang Seng Index up 135 points or 0.55%, reporting at 24,992 points. The National Index rose 79 points or 1%, reporting at 8,469 points. Several blue-chip companies announced their earnings, with Meituan's stock price rising 1.7%, SMIC falling 0.5%, and China Mobile rising 0.4%. Pharmaceutical stocks generally rose, with CSPC PHARMA's stock price increasing by 9.6%. BYD rose 4.3%, and Leapmotor rose 5.5%. The total turnover of the market for the half-day was HKD 135.775 billion

Hua Xia CSI New Energy Vehicles ETF

BYD Company

BYD Company Limited

"Hong Kong Stocks" Hang Seng Index rises 135 points in half a day, BYD up over 4%, CSPC PHARMA rises by 10%

03393

02661

The Hang Seng Index closed at 24,992 points, up 135 points or 0.5%; the Hang Seng Tech Index reported 4,811 points, up 50 points or 1.1%. The National Index rose 79 points or 1.0%, closing at 8,469 points. Among the active blue-chip stocks, Meituan rose 1.7%, Xiaomi rose 1.7%, Alibaba rose 0.3%, and Tencent slightly fell by 0.1%. CSPC Pharma had the largest increase, rising 9.6%, while XUNCE reached a new high, rising 22.9%

WASION HOLDINGS

QINGSONG HEALTH

The "Half-Day Express" reports that the Hang Seng Index closed at 24,992 points, up 135 points; the Hang Seng Tech Index closed at 4,811 points, up 50 points. CSPC Pharma rose over 9%, XUNCE, WASION HOLDINGS, Ganfeng Lithium, QINGSONG HEALTH, and HUISHANG BANK reached new highs

Jefferies analyst Chu Wang has maintained a Sell rating on CSPC Pharmaceutical Group (CHJTF) with a price target of HK$7.20, while the shares closed at HK$8.49. Despite Wang's average return of -6.2% and a 66.67% success rate, the analyst consensus for CSPC is Strong Buy, with a target of HK$13.53.

Jefferies Sticks to Their Sell Rating for CSPC Pharmaceutical Group (CHJTF)

From October 1, 2025 to December 31, 2025, the company has repurchased 0 shares, representing 0% for HKD 0 million. With this, the company has completed the repurchase of 102,570,847 shares, representing 0.88% for HKD 525.36 million under the buyback announced on September 19, 2024.

marketscreener

Tranche Update on CSPC Pharmaceutical Group Limited's Equity Buyback Plan announced on September 19, 2024.

Hot trading industry trends on August 7 and related Hong Kong semiconductor stocks. Hong Kong semiconductor stocks opened lower in early trading but then surged strongly, with Innoscience gaining over 11%, and industry leader SMIC rising over 3%. Core logic: On the news front, on August 1, Innoscience officially responded to rumors of collaboration with NVIDIA. The announcement stated that the company has recently partnered with global AI technology leader NVIDIA to jointly promote the large-scale implementation of the 800VDC (800-volt direct current) power architecture in AI data centers. Clear signals of a cyclical bottom: Global semiconductor inventory reduction is nearing its end...

NVIDIA

SMIC

SMIC HK SDR 5to1

SJM HOLDINGS

MGM CHINA

FIT HON TENG

WUXI APPTEC

WuXi AppTec

XIAOMI-W

XIAOMI-WR

Xiaomi HK SDR 2to1

Xiaomi Corporation

GALAXY ENT

Galaxy Entertainment Group

NAGACORP

WYNN MACAU

MELCO INT'L DEV

SANDS CHINA LTD

Sands China

COWELL

HUA HONG SEMI

Hua Hong

SHANGHAI FUDAN

FMSH

INNOSCIENCE

SOLOMON SYSTECH

TIGERMED

Tigermed

Apple

Hot Trades in Hong Kong Stocks (8.7)｜ Chip Stocks Rebound Strongly, Apple Supply Chain Follows; Xiaomi and Pharmaceuticals Retreat Under Pressure

Hong Kong stocks continued their upward trend on July 28, with the cryptocurrency, innovative drug, gaming, and insurance sectors performing well. Hong Kong's &#34;Stablecoin Ordinance&#34; will officially take effect on August 1, marking the countdown to stablecoin issuance; the innovative drug sector was boosted by Hengrui Pharmaceuticals securing a $12 billion order; insurance stocks extended their gains as industry anti-internal competition and interest rate cuts improved profit prospects; gaming stocks benefited from Macau's July gaming revenue exceeding expectations and Thailand's withdrawal of the casino bill.

Hengrui Pharma

3SBIO

OSL GROUP

CPIC

SUNSHINE INS

CR HOLDINGS

CHINA LIFE

China Life

SINO BIOPHARM

GUOTAI JUNAN I

AIA-R

AIA Group

Hot Trades in Hong Kong Stocks (7.28)｜Cryptocurrency, Innovative Drugs, Insurance, and Gaming Sectors Shine, Hengrui Pharmaceuticals Soars 15% at Midday

BI-CSPC@EC2611A(26561.HK)

BI-CSPC@EC2611A Stock Performance Chart

CSPC Pharmaceutical Group (CHJTF) was upgraded to a Hold Rating at Bank of China

"Hong Kong Stocks" Hang Seng Index closed up 95 points, pharmaceutical stocks led the rise, CSPC PHARMA surged nearly 14%

Top 5 HK Stock Gainers/Losers (>100B) (3.27)

Top 10 HK Stock Gainers (3.27)

According to the "All-Day Express," the Hang Seng Index closed at 24,951 points, up 95 points; the Hang Seng Tech Index closed at 4,778 points, up 16 points. CSPC Pharma rose over 13%, XUNCE, Ganfeng Lithium, Weisheng Holdings, Qingsong Health, and HUISHANG BANK reached new highs with active trading